Call(WhatsApp Us)
+8618988990383Email Us
postmaster@laeyolabs.com广州市花都区花山镇华辉路18号
微观化妆品创意产业园E栋整栋For any brand sourcing sunscreen formulations intended for sale in the U.S., understanding when your product triggers the need for an FDA-compliant “Drug Facts” label is essential. This guide explains how to classify your…
For any brand sourcing sunscreen formulations intended for sale in the U.S., understanding when your product triggers the need for an FDA-compliant “Drug Facts” label is essential. This guide explains how to classify your sunscreen, what labeling and testing responsibilities apply, and provides a practical buyer checklist to help you avoid import delays or product recalls.
In the United States, sunscreens are regulated as over-the-counter (OTC) drugs under the FDA’s Monograph system. The moment your product claims to prevent sunburn or reduce the risk of skin cancer or early skin aging caused by the sun, it must comply with OTC regulations and carry a full “Drug Facts” panel.
To verify compliance, conduct an ingredient screening and match each active ingredient against FDA monograph-approved UV filters (e.g., Zinc Oxide, Titanium Dioxide, Avobenzone, Homosalate). Non-monograph actives or blends typically require a New Drug Application (NDA), which is not feasible for most private-label buyers.
| Ingredient Status | Regulatory Pathway | Evidence Required |
|---|---|---|
| Monograph active (e.g., Zinc Oxide) | OTC Monograph Compliant | SPF/Broad-Spectrum test; COA; label review |
| Non-monograph UV filter | NDA (not for private-label) | Clinical data; FDA registration |
When a sunscreen is classified as an OTC product, its packaging and documentation must align with FDA labeling standards. Below are key documentation checkpoints:
□ Confirm active ingredients match FDA monograph list.
□ Obtain SPF and Broad-Spectrum test reports (FDA protocol).
□ Request full “Drug Facts” label artwork for review.
□ Verify manufacturer FDA establishment registration number.
□ Request drug listing or registration confirmation for formula.
□ Review batch record format for OTC compliance (traceable lots).
□ Ensure packaging layout accommodates compliant panel.
□ Review claims with regulatory consultant (water resistance, protection).
□ Obtain COA for each active and inactive raw material.
□ Validate expiration date from stability and micro data.
No. Any sunscreen that makes UV protection claims requires the “Drug Facts” panel under OTC rules.
Yes. As soon as SPF or sun protection claims appear, the product is an OTC sunscreen—even if it also has cosmetic benefits.
Both types are covered under the same CBD monograph, though actives differ. Zinc Oxide and Titanium Dioxide are considered safe and effective, while some chemical UV filters are under additional FDA review.
Establishment registration must be renewed annually. Product listings should be updated for every formula change or new SKU.
Yes, but they must appoint a U.S. agent and comply with all GMP and labeling requirements outlined under 21 CFR parts 207 and 211.
If you are sourcing sunscreen formulations for the U.S. market, establish early clarity on monograph compliance, active filters, and labeling structure. A compliant “Drug Facts” label is not optional — it is your first defense against costly detentions and recalls. Partner only with manufacturers experienced in OTC production and FDA registration processes.
Request a Quote to review your sunscreen formula and receive a compliant OTC documentation pack.